Crossmark

Study protocol: The Dutch 20|30 Postmeningitis study: a cross-sectional follow-up of two historical childhood bacterial meningitis cohorts on long-term outcomes

Crossref DOI link: https://doi.org/10.1186/s12887-019-1900-1

Published Online: 2019-12-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

El Tahir, O. https://orcid.org/0000-0002-1387-292X
de Jonge, R. C. J.

Ouburg, S.

Morré, S. A.

van Furth, A. M.
Funding

Funding for this research was provided by:

GlaxoSmithKline
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-30
More Information

Article History

Received: 22 April 2019

Accepted: 22 December 2019

First Online: 30 December 2019

Ethics approval and consent to participate

: Ethical approval was obtained from the VU University Medical Center Amsterdam on 3rd August 2017 under the corresponding number: 2017.292. Written informed consent was and will be obtained from all participants. The Medical Ethics Review Committee of VU University Medical Center is registered with the US Office for Human Research Protections (OHRP) as IRB00002991. The FWA number assigned to VU University Medical Center is FWA00017598.

: Not applicable.

: This study has received funding from GlaxoSmithKline Biologicals SA and has undergone peer review by the funding organization. All authors declare that they have no competing interests.

Document is current

Any future updates will be listed below